kynurenic acid has been researched along with adenosine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chernevskaya, NI; Krishtal, OA; Obukhov, AG | 1 |
| Appalsamy, M; Beck, C; Mosqueda-Garcia, R; Robertson, D; Tseng, CJ | 1 |
| Garashchuk, OV; Koval'chuk, IuN; Kryshtal', OA | 1 |
| Craig, CG; White, TD | 1 |
| Addae, JI; Stone, TW | 1 |
| Kocsis, JD; Malenka, RC | 1 |
| Cotman, CW; Harris, EW | 1 |
| Stone, TW | 1 |
| Iadecola, C; Li, J | 1 |
| Bellingham, MC; Berger, AJ | 1 |
| Akhondzadeh, S; Stone, TW | 1 |
| Dickenson, AH; Kerr, NC; Reeve, AJ | 1 |
| O'Leary, DS; Scislo, TJ | 2 |
| Fuxe, K; Schwarcz, R; Wu, HQ | 1 |
| Benedek, G; Csullog, E; Horvath, G; Joo, G; Kekesi, G; Peter-Szabo, M | 1 |
| Benedek, G; Horvath, G; Kekesi, G; Tuboly, G | 1 |
| Fatokun, AA; Smith, RA; Stone, TW | 1 |
| Amori, L; Guidetti, P; Marinozzi, M; Pellicciari, R; Schwarcz, R; Wu, HQ | 1 |
| Oka, S; Ota, R; Shima, M; Sugiura, T; Yamashita, A | 1 |
| Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S | 1 |
1 review(s) available for kynurenic acid and adenosine
| Article | Year |
|---|---|
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan | 2022 |
21 other study(ies) available for kynurenic acid and adenosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
NMDA receptor agonists selectively block N-type calcium channels in hippocampal neurons.
Topics: 2-Amino-5-phosphonovalerate; Adenosine; Aspartic Acid; Calcium; Calcium Channels; Glutamates; Hippocampus; Kynurenic Acid; Mollusk Venoms; N-Methylaspartate; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1991 |
Cardiovascular excitatory effects of adenosine in the nucleus of the solitary tract.
Topics: Adenosine; Animals; Blood Pressure; Glutamates; Glutamic Acid; Heart Rate; Kynurenic Acid; Male; Medulla Oblongata; Rats; Rats, Inbred Strains; Saralasin | 1991 |
[Analysis of synaptic transmission in rat hippocampal slices using a modified method of potential fixation].
Topics: Adenosine; Animals; Evoked Potentials; Glutamates; Glutamic Acid; Hippocampus; In Vitro Techniques; Kynurenic Acid; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Synapses; Synaptic Transmission | 1991 |
Endogenous glycine modulates N-methyl-D-aspartate-evoked release of adenosine and [3H]noradrenaline from rat cortical slices.
Topics: Adenosine; Animals; Cerebral Cortex; Glycine; In Vitro Techniques; Kynurenic Acid; Male; N-Methylaspartate; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Strychnine | 1991 |
Purine receptors and kynurenic acid modulate the somatosensory evoked potential in rat cerebral cortex.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cerebral Cortex; Evoked Potentials, Somatosensory; Kynurenic Acid; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Synaptic Transmission | 1988 |
Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro.
Topics: Action Potentials; Adenosine; Animals; Atropine; Carbachol; Cerebral Cortex; Corpus Striatum; Dopamine; Female; In Vitro Techniques; Kynurenic Acid; Neural Pathways; Rats; Rats, Inbred Strains; Synaptic Transmission; Tetrodotoxin; Theophylline | 1988 |
Effects of synaptic antagonists on perforant path paired-pulse plasticity: differentiation of pre- and postsynaptic antagonism.
Topics: Adenosine; Animals; Baclofen; Electric Stimulation; Hippocampus; Kynurenic Acid; Male; Neural Pathways; Neuronal Plasticity; Rats; Synaptic Transmission | 1985 |
Interactions of carbamazepine, chlormethiazole and pentobarbitone with adenosine on hippocampal slices.
Topics: 2-Chloroadenosine; Adenosine; Amino Acids; Animals; Carbamazepine; Chlormethiazole; Hippocampus; In Vitro Techniques; Iontophoresis; Kynurenic Acid; Male; Muscle Relaxants, Central; Pentobarbital; Rats; Receptors, Purinergic; Synapses | 1988 |
Nitric oxide and adenosine mediate vasodilation during functional activation in cerebellar cortex.
Topics: Adenosine; Amino Acid Oxidoreductases; Animals; Bicuculline; Blood Gas Analysis; Blood Pressure; Cerebellar Cortex; Cerebrovascular Circulation; Electric Stimulation; Kynurenic Acid; Male; Membrane Potentials; Nerve Fibers; Nitric Oxide; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Vasodilation | 1994 |
Adenosine suppresses excitatory glutamatergic inputs to rat hypoglossal motoneurons in vitro.
Topics: 2-Chloroadenosine; Action Potentials; Adenosine; Animals; Female; Hypoglossal Nerve; Kynurenic Acid; Male; Membrane Potentials; Motor Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Purinergic P1; Xanthines | 1994 |
Glutamate-independent long term depression in rat hippocampus by activation GABAA receptors.
Topics: 2-Amino-5-phosphonovalerate; Adenosine; Alanine; Animals; Cycloleucine; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Glutamic Acid; Hippocampus; In Vitro Techniques; Kinetics; Kynurenic Acid; Male; Muscimol; Neuronal Plasticity; Neurotoxins; Pyramidal Cells; Rats; Rats, Wistar; Receptors, GABA-A | 1996 |
Spinal effects of bicuculline: modulation of an allodynia-like state by an A1-receptor agonist, morphine, and an NMDA-receptor antagonist.
Topics: Adenosine; Animals; Bicuculline; Dose-Response Relationship, Drug; GABA Antagonists; Kynurenic Acid; Male; Morphine; Naloxone; Nerve Fibers; Neurons; Pain; Physical Stimulation; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Touch | 1998 |
Differential role of ionotropic glutamatergic mechanisms in responses to NTS P(2x) and A(2a) receptor stimulation.
Topics: Adenosine; Adenosine Triphosphate; Adrenal Glands; Animals; Excitatory Amino Acid Antagonists; Hemodynamics; Kidney; Kynurenic Acid; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Glutamate; Receptors, Purinergic P1; Receptors, Purinergic P2; Solitary Nucleus; Sympathetic Nervous System | 2000 |
Mechanisms mediating regional sympathoactivatory responses to stimulation of NTS A(1) adenosine receptors.
Topics: Adenosine; Animals; Aorta; Blood Pressure; Excitatory Amino Acid Antagonists; Heart Rate; Kidney; Kynurenic Acid; Male; Microinjections; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Solitary Nucleus; Sympathetic Nervous System; Vagotomy | 2002 |
Neuronal A1 receptors mediate increase in extracellular kynurenic acid after local intrastriatal adenosine infusion.
Topics: Adenosine; Animals; Drug Administration Routes; Extracellular Fluid; Infusions, Parenteral; Kynurenic Acid; Male; Microdialysis; Neostriatum; Neurons; Phenethylamines; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Theophylline; Wakefulness | 2004 |
Dose-independent antinociceptive interaction of endogenous ligands at the spinal level.
Topics: Adenosine; Agmatine; Analgesics; Animals; Carrageenan; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Excitatory Amino Acid Antagonists; Hyperalgesia; Injections, Spinal; Kynurenic Acid; Ligands; Male; Pain Threshold; Rats; Rats, Wistar; Reaction Time | 2004 |
Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level.
Topics: Adenosine; Agmatine; Analgesics; Animals; Area Under Curve; Disease Models, Animal; Drug Combinations; Injections, Spinal; Kynurenic Acid; Ligands; Male; Motor Activity; Oligopeptides; Pain; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Spinal Cord | 2007 |
Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Apoptosis; Cell Death; Cell Survival; Cells, Cultured; Cerebellum; Cytarabine; Glutamic Acid; Kynurenic Acid; Necrosis; Neurons; Rats; Rats, Sprague-Dawley; Xanthines | 2008 |
Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
Topics: Adenosine; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Fluid; Functional Laterality; Kynurenic Acid; Kynurenine; Mice; Mice, Knockout; Microdialysis; Nerve Degeneration; Norbornanes; Quinolinic Acid; Transaminases; Tritium | 2009 |
GPR35 is a novel lysophosphatidic acid receptor.
Topics: Adenosine; Calcium; Cannabinoid Receptor Agonists; Cell Line; Extracellular Signal-Regulated MAP Kinases; Humans; Kynurenic Acid; Ligands; Lysophospholipids; Purinones; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein | 2010 |